Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06636318

Immune Status After Being on Call for 24 Hrs

Impact of a 24-hour Shift Call on the Immune Status of Surgery Residents

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Sleep deprivation is a prevalent problem in modern societies. Sleep deprivation can cause hormonal changes, such as an increase in cortisol, as well as inflammation. Animal studies have shown an increase in inflammatory cytokine production following sleep deprivation. Additionally, humans experiencing sleep deprivation may experience a decrease in natural killer cells and lymphocytes. Physicians, particularly those in surgical specialties, are often subjected to sleep deprivation as part of their medical residency training. This study hypothesizes that after 24-hour shifts, there is an increase in inflammatory response and impairment of the immune response against unspecific activation. This proposal aims to provide insight into the impact of sleep deprivation on the immune system of surgery residents by characterizing the phenotype and function of immune cells, as well as their correlation with biometric data.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood Sample CollectionTo characterize the phenotype and function of immune cells in surgery residents before and after a 24-hour shift, and before and after a month of being "on call". Along with to investigate the relationship between sleep deprivation, physical activity, and different immune responses.
DEVICEActigraph (GT9X-BT) MonitorParticipants will be asked to wear their monitor every day for a week. The monitor will collect their step count, sleep and heart rate automatically. Participants will return their monitor at visit 5 (day 30) of the study.

Timeline

Start date
2024-10-17
Primary completion
2027-12-01
Completion
2027-12-01
First posted
2024-10-10
Last updated
2025-12-09

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06636318. Inclusion in this directory is not an endorsement.